助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[108]条 当前为第21条到40条[由于搜索限制,当前仅支持显示前5页数据]
 

相关语句
renal-cell
Semiquantitative analysis of Th1 and Th2 cytokine expression in CD3+, CD4+, and CD8+renal-cell-carcinoma-infiltrating lymphocyte
      
The tests proved to be successful in 22 out of 33 urothelial transitional-cell carcinomas, 21 out of 29 renal-cell carcinomas, and in 8 out of 13 testicular tumors, but in 0 out of 4 Wilms' tumors.
      
However, renal-cell carcinomas exhibited a low sensitivity rate of 38% even when exposed to the peak plasma level.
      
The pharmacokinetics of rIFNα-C were studied in 11 patients with metastatic renal-cell carcinoma.
      
Cortical blindness was diagnosed in a 75-year-old man who had been treated with alpha-interferon for metastatic renal-cell carcinoma.
      
Adjuvant chemotherapy with vinblastine, Adriamycin, and UFT for renal-cell carcinoma
      
VAU therapy (vinblastine, Adriamycin, and UFT) was given postoperatively to 31 patients with stage I, II, or III renal-cell carcinoma, and the incidence of relapse as well as the survival of patients were studied.
      
These results were significantly better (P>amp;lt;0.01) than the respective values (81%, 72%, and 60%) obtained for the historical controls, i.e., the 60 patients with stage I, II, or III renal-cell carcinoma who received no chemotherapy.
      
As VAU therapy might be useful as adjuvant chemotherapy for renal-cell carcinoma, it seems to merit further study.
      
Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cance
      
Antitumor effects of oral administration of an interferon-inducing pyrimidinone, Bropirimine, on murine renal-cell carcinoma
      
Experiments were designed to explore the possibility of using this drug for the treatment of renal-cell carcinoma (RCC).
      
High-dose toremifene in advanced renal-cell carcinoma
      
The purpose of the present study was to investigate the effect and tolerability of high-dose toremifene in the treatment of patients with advanced renal-cell carcinoma (RCC).
      
Phase II trial of titanocene dichloride in advanced renal-cell carcinoma
      
A total of 14 patients with metastatic renal-cell carcinoma (RCC) received 270?mg/m2 titanocene dichloride every 3 weeks for 6 weeks.
      
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcino
      
Epidermal growth factor receptor (EGFR) expression has been associated with clinical outcome in some studies of renal-cell carcinoma (RCC).
      
This technique was applied in the case of a renal-cell carcinoma in the lower half of a solitary left kidney.
      
Proliferative behaviour and cytogenetic changes in human renal-cell carcinoma
      
 

首页上一页12345下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社